Drug Delivery Systems for Cancer Treatment

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 965

Special Issue Editors


E-Mail Website
Guest Editor
Milwaukee School of Engineering, Milwaukee, WI, USA
Interests: biomaterials; drug delivery; micro/nanotechnology; tissue engineering; cancer treatment
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Mechanical Engineering, Vellore Institute of Technology, Vellore 632014, India
Interests: biomaterials; nanocarriers; stem cells; drug delivery; organ engineering
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cancer remains a leading cause of death, although significant progresses have been made toward cancer treatment. Novel drug delivery systems are critical toward effective cancer treatment in addition to the discovery of drug molecules themselves. Novel drug delivery systems of various scales and shapes show great promise in improving cancer treatment efficacy, especially in relieving drug resistance. Some state-of-the-art approaches include targeting cancer cells and releasing drugs utilizing tumor microenvironment-responsiveness of the drug carriers. Moreover, drug delivery to cancer stem-like cells needs further research as they are highly involved in drug resistance and metastasis.

This Special Issue on “Novel Drug Delivery Systems for Cancer Treatment” focuses on original research papers and comprehensive reviews which investigate multiscale novel drug delivery systems for effective cancer treatment, especially targeting cancer stem-like cells and drug resistance. Topics of interest for this Special Issue include but are not limited to the following:

  1. Novel microscale drug delivery systems, such as microspheres and microcapsules, for cancer treatment;
  2. Novel nanoscale drug delivery systems, such as nanoparticles and nanofibers, for cancer treatment;
  3. Novel targeted drug delivery systems for cancer treatment;
  4. Development of in vitro tumor models for anti-cancer therapeutics testing;
  5. Tumor microenvironment-responsive, such as heat and pH, drug delivery systems for cancer treatment;
  6. Novel drug delivery systems overcoming cancer cell drug resistance;
  7. Drug delivery to cancer stem-like cells.

Dr. Wujie Zhang
Prof. Dr. Murugan Ramalingam
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug delivery
  • cancer treatment
  • controlled release
  • sustained release
  • drug targeting
  • microcarrier
  • nanocarrier
  • tumor microenvironment-responsive
  • cancer stem-like cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop